Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human papillomaviruses

D J McCance1

  • 1University of Rochester School of Medicine and Dentistry, New York.

Infectious Disease Clinics of North America
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

This article examines human papillomaviruses (HPVs) linked to lower genital tract cancers. It details HPV

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA2 receptor.

Oncogene·2007
Same author

The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent manner.

Oncogene·2007
Same author

Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6.

Oncogene·2005
Same author

Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Journal of virology·2004
Same author

Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression.

Journal of virology·2003
Same author

Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.

Journal of virology·2002
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Area of Science:

  • Gynecologic Oncology
  • Virology
  • Molecular Diagnostics

Background:

  • Human papillomaviruses (HPVs) are oncogenic viruses frequently associated with premalignant and malignant lesions of the lower genital tract.
  • Understanding the epidemiology and molecular mechanisms of HPV infection is crucial for disease prevention and management.

Purpose of the Study:

  • To review the role of specific HPVs in the development of premalignant and malignant diseases of the lower genital tract.
  • To discuss the prevalence of HPV infection and associated diseases across different age demographics.
  • To outline current methodologies for detecting HPV DNA in clinical specimens.

Main Methods:

  • Literature review focusing on HPV's role in cervical, vulvar, and vaginal diseases.
  • Analysis of epidemiological data regarding HPV infection frequency in various age groups.

Related Experiment Videos

  • Description of diagnostic techniques for HPV DNA detection in cervical cells and biopsies.

    • Main Results:

    • Certain HPV types are strongly implicated in the etiology of lower genital tract cancers.
    • HPV infection prevalence varies significantly with age, with peak incidence in younger populations.
    • Various molecular assays are available for sensitive and specific HPV DNA detection.

    Conclusions:

    • HPVs are key causative agents in lower genital tract premalignant and malignant conditions.
    • Age-specific epidemiological data informs targeted screening and prevention strategies.
    • Accurate HPV DNA testing is essential for risk stratification and clinical decision-making.